Proof of concept and development of a couple-based machine learning model to stratify infertile patients with idiopathic infertility.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 12 2021
Historique:
received: 08 07 2021
accepted: 18 11 2021
entrez: 15 12 2021
pubmed: 16 12 2021
medline: 28 1 2022
Statut: epublish

Résumé

We aimed to develop and evaluate a machine learning model that can stratify infertile/fertile couples on the basis of their bioclinical signature helping the management of couples with unexplained infertility. Fertile and infertile couples were recruited in the ALIFERT cross-sectional case-control multicentric study between September 2009 and December 2013 (NCT01093378). The study group consisted of 97 infertile couples presenting a primary idiopathic infertility (> 12 months) from 4 French infertility centers compared with 100 fertile couples (with a spontaneously conceived child (< 2 years of age) and with time to pregnancy < 12 months) recruited from the healthy population of the areas around the infertility centers. The study group is comprised of 2 independent sets: a development set (n = 136 from 3 centers) serving to train the model and a test set (n = 61 from 1 center) used to provide an unbiased validation of the model. Our results have shown that: (i) a couple-modeling approach was more discriminant than models in which men's and women's parameters are considered separately; (ii) the most discriminating variables were anthropometric, or related to the metabolic and oxidative status; (iii) a refined model capable to stratify fertile vs. infertile couples with accuracy 73.8% was proposed after the variables selection (from 80 to 13). These influential factors (anthropometric, antioxidative, and metabolic signatures) are all modifiable by the couple lifestyle. The model proposed takes place in the management of couples with idiopathic infertility, for whom the decision-making tools are scarce. Prospective interventional studies are now needed to validate the model clinical use.Trial registration: NCT01093378 ALIFERT https://clinicaltrials.gov/ct2/show/NCT01093378?term=ALIFERT&rank=1 . Registered: March 25, 2010.

Identifiants

pubmed: 34907216
doi: 10.1038/s41598-021-03165-3
pii: 10.1038/s41598-021-03165-3
pmc: PMC8671584
doi:

Banques de données

ClinicalTrials.gov
['NCT01093378']

Types de publication

Clinical Trial Comparative Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24003

Investigateurs

Isabelle Aknin (I)
Isabelle Cedrin-Durnerin (I)
Steven Cens (S)
Nathalie di Clemente (N)
Jean-Louis Guéant (JL)
Serge Hercberg (S)
Yoann Lalatonne (Y)
Chrystèle Racine (C)
Nathalie Sermondade (N)
Angela Sutton (A)
Claude Uthurriague (C)
Jean-Philippe Wolf (JP)
Alain Favier (A)

Informations de copyright

© 2021. The Author(s).

Références

Ann Intern Med. 2009 May 5;150(9):626-31
pubmed: 19414842
Reprod Biomed Online. 2012 Jun;24(6):591-602
pubmed: 22503948
Fertil Steril. 2004 Feb;81(2):384-92
pubmed: 14967378
Fertil Steril. 2009 Nov;92(5):1520-4
pubmed: 19828144
J Endocr Soc. 2017 Feb 10;1(3):186-201
pubmed: 29264476
Hum Reprod Update. 2017 Jul 1;23(4):371-389
pubmed: 28333357
Fertil Steril. 2018 Sep;110(4):587-592
pubmed: 30196942
Reprod Biomed Online. 2011 Oct;23(4):421-39
pubmed: 21885344
Metabolism. 2013 Apr;62(4):457-78
pubmed: 22999785
Reprod Biomed Online. 2015 Nov;31(5):593-604
pubmed: 26380863
JAMA. 2019 Oct 8;322(14):1351-1352
pubmed: 31393527
Fertil Steril. 2017 Apr;107(4):840-847
pubmed: 28292619
BMJ. 2004 Feb 21;328(7437):447-51
pubmed: 14976101
Brief Bioinform. 2018 Nov 27;19(6):1356-1369
pubmed: 29106465
BMC Pregnancy Childbirth. 2020 May 26;20(1):322
pubmed: 32456614
JAMA. 2003 Oct 1;290(13):1767-70
pubmed: 14519712
J Proteome Res. 2015 Aug 7;14(8):3322-35
pubmed: 26088811
Epidemiology. 2002 Mar;13(2):184-90
pubmed: 11880759
Asian J Androl. 2013 Sep;15(5):622-5
pubmed: 23792341
Arch Intern Med. 2012 Mar 12;172(5):440-442
pubmed: 22412113
Reprod Biomed Online. 2018 Apr;36(4):459-471
pubmed: 29452915
Respir Med. 2004 Jun;98(6):551-6
pubmed: 15191041
Basic Clin Androl. 2019 Jul 1;29:9
pubmed: 31304019
Fertil Steril. 2018 Sep;110(4):560-569
pubmed: 30196938
Hum Reprod. 2007 Jun;22(6):1634-7
pubmed: 17344224
JAMA. 2019 Dec 17;322(23):2283-2284
pubmed: 31755902
Sci Rep. 2021 Sep 13;11(1):18160
pubmed: 34518615
Int J Fertil Steril. 2018 Apr;12(1):19-26
pubmed: 29334202
J Gerontol A Biol Sci Med Sci. 2007 Mar;62(3):308-16
pubmed: 17389729
Am J Clin Nutr. 2009 Aug;90(2):329-35
pubmed: 19491388
PLoS One. 2019 Apr 24;14(4):e0210770
pubmed: 31017887
Antioxid Redox Signal. 2014 Aug 1;21(4):565-9
pubmed: 24444339
Hum Reprod. 2016 Sep;31(9):2108-18
pubmed: 27365525
PLoS One. 2014 Feb 10;9(2):e86300
pubmed: 24520319
Hum Genet. 2003 May;112(5-6):581-92
pubmed: 12607117

Auteurs

Guillaume Bachelot (G)

Service de Biologie de La Reproduction-CECOS, Hôpital Tenon, AP-HP/Sorbonne Université, 75020, Paris, France.

Rachel Lévy (R)

Service de Biologie de La Reproduction-CECOS, Hôpital Tenon, AP-HP/Sorbonne Université, 75020, Paris, France.
Sorbonne Université, Saint Antoine Research Center, INSERM UMR 938, 75012, Paris, France.

Anne Bachelot (A)

Service d'Endocrinologie et Médecine de La Reproduction, Centre de Référence Des Maladies Endocriniennes Rares de La Croissance et du Développement, Centre Des Pathologies Gynécologiques Rares, Hôpital Pitié Salpêtrière (APHP), Sorbonne Université, 75013, Paris, France.

Céline Faure (C)

Service de Biologie de La Reproduction-CECOS, Hôpital Tenon, AP-HP/Sorbonne Université, 75020, Paris, France.

Sébastien Czernichow (S)

Université de Paris, INSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS team, Service de Nutrition, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.

Charlotte Dupont (C)

Service de Biologie de La Reproduction-CECOS, Hôpital Tenon, AP-HP/Sorbonne Université, 75020, Paris, France.
Sorbonne Université, Saint Antoine Research Center, INSERM UMR 938, 75012, Paris, France.

Antonin Lamazière (A)

Sorbonne Université, Saint Antoine Research Center, INSERM UMR 938, 75012, Paris, France. antonin.lamaziere@aphp.fr.
Département de Métabolomique Clinique, Hôpital Saint Antoine, AP-HP/Sorbonne Université, 27 Rue Chaligny, 75012, Paris, France. antonin.lamaziere@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH